NHS Will Pay For AstraZeneca Lung Cancer Drug Imfinzi
LONDON (Alliance News) - AstraZeneca PLC's lung cancer drug Imfinzi will be paid for by the UK National Health Service for use by eligible patients following approval by a UK regulator, it was Read More